TITLE

Impact of the agr Quorum-Sensing System on Adherence to Polystyrene in Staphylococcus aureus

AUTHOR(S)
Cuong Vuong; Saenz, Henri L.; Gotz, Friedrich; Otto, Michael
PUB. DATE
December 2000
SOURCE
Journal of Infectious Diseases;12/1/2000, Vol. 182 Issue 6
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Biofilm formation by Staphylococcus aureus is a serious problem in nosocomial infections. There are great differences in the capacity of S. aureus to express biofilms, but the reasons are unknown. In all, 105 S. aureus strains were tested for a correlation between the agr quorum-sensing system phenotype and the ability of S. aureus to adhere to polystyrene. Some 78% of agr-negative, but only 6% of agr-positive, strains formed a biofilm, demonstrating a profound impact of agr on biofilm formation. This result was confirmed with defined agr mutants and by inhibition of agr with quorum-sensing blockers. The observed effect was not due to differential expression of the autolysin Atl or of the exopolysaccharide polysaccharide intercellular adhesin but seemed to be caused, at least in part, by the surfactant properties of delta-toxin. The detected biofilm-enhancing effect of S. aureus quorum-sensing blockers call into question the proposed therapeutic use of such substances.
ACCESSION #
5098692

 

Related Articles

  • Norway Stops Superbug.  // Current Science;4/16/2010, Vol. 95 Issue 15, p14 

    The article reports on the move of the Norwegian government to cut back on too much use of antibiotics for the treatment of Staphylococcus aureus infections (MRSA) among patients which have yielded into positive results and reduced the number of people infected by the bacteria.

  • Assessment of risk factors in the development of MRSA infection at Gülhane Military Medical Faculty Education Hospital and the role of antibiotic use on the development of MRSA infection. Gunal, E.; Besirbellioglu, B. A.; Ersoz, F.; Avci, I. Y.; Eyigun, C. P. // BMC Proceedings;Jan2011 Supplement 6, Vol. 5, pP14 

    An abstract of the article "Assessment of risk factors in the development of MRSA infection at Guelhane Military Medical Faculty Education Hospital and the role of antibiotic use on the development of MRSA infection," by E. Gunal, F. Ersoz and C. P. Eyigun is presented.

  • STREP COVERAGE WITH POTENTIAL MRSA?  // Clinical Advisor;Sep2009, Vol. 12 Issue 9, p34 

    The article presents an answer to a question on antibiotics that can be used to treat methicillin-resistant Staphylococcus aureus (MSRA).

  • Short-course therapy of catheter-related Staphylococcus aureus bacteremia: a meta-analysis. Jernigan, John A.; Farr, Barry M.; Jernigan, J A; Farr, B M // Annals of Internal Medicine;8/15/93, Vol. 119 Issue 4, p304 

    Objective: To determine, through structured methodologic review of published articles, the effectiveness of short-course (< or = 2 weeks) antibiotic therapy for catheter-related Staphylococcus aureus bacteremia.Data Sources: English-language publications on...

  • Failure of Clindamycin Treatment of Methicillin-Resistant Staphylococcus aureus Expressing Inducible Clindamycin Resistance In Vitro.  // Clinical Infectious Diseases;11/1/2003, Vol. 37 Issue 9, p1257 

    We report a case of a surgical site infection caused by clindamycin-susceptible, erythromycin-resistant methicillin-resistant Staphylococcus aureus (MRSA) that did not respond to treatment with clindamycin. The MRSA isolate obtained after treatment was resistant to clindamycin but was found to...

  • Diversity in the antimicrobial susceptibility patterns of methicillin-resistant Staphylococcus aureus clones. Ghaznavi-Rad, E.; Neela, V.; Nor Shamsudin, M.; Ghasemzadeh Moghaddam, H.; Tavakol, M.; Belkum, A.; Etemadi, M.; Andar-Ali, A. // European Journal of Clinical Microbiology & Infectious Diseases;Dec2012, Vol. 31 Issue 12, p3317 

    Methicillin-resistant Staphylococcus aureus (MRSA) is well known for its epidemicity, with the emergence of new clones on a daily basis. Diversity in the clonal types of MRSA challenges the success of treatment, as different clones respond to different sets of antibiotics. However, the...

  • Linezolid bested vancomycin in MRSA ventilator-associated pneumonia.  // Infectious Disease News;Jun2011, Vol. 24 Issue 6, p26 

    The article reports on the association of linezolid with better outcomes in patients with methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia compared with those assigned vancomycin.

  • Another anti-MRSA agent making its way to the market. Boeser, Kimberly // Infectious Disease News;Nov2009, Vol. 22 Issue 11, p18 

    This article offers information on telavancin, a new anti-methicillin resistant Staphylococcus aureus (MRSA) agent indicated for adult patients with complicated skin and skin structure infections.

  • Audit of treatment of Staphylococcus aureus bacteraemia. Wong, V.; Wariyar, R.; Weston, V.; Youngs, E.; Hussain, A.; Perera, N.; Swann, A.; Olver, W. J. // Clinical Medicine;Jun2010, Vol. 10 Issue 3, p266 

    Staphylococcus aureus bacteraemia remains a significant cause of morbidity and mortality. National guidelines recommend that a minimum of 14 days of antibiotics should be used to treat uncomplicated bacteraemia. Five hospitals in the East Midlands region conducted a retrospective audit to assess...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics